Analysts have been eager to weigh in on the Healthcare sector with new ratings on CureVac (CVAC – Research Report), Marinus (MRNS – Research Report) and Vertex Pharmaceuticals (VRTX – Research Report).
CureVac (CVAC)
Jefferies analyst Eun Yang maintained a Buy rating on CureVac yesterday and set a price target of $21.00. The company’s shares closed last Tuesday at $4.10, close to its 52-week low of $3.41.
According to TipRanks.com, Yang is a 4-star analyst with an average return of
Currently, the analyst consensus on CureVac is a Moderate Buy with an average price target of $13.08, implying a 262.3% upside from current levels. In a report released yesterday, JMP Securities also reiterated a Buy rating on the stock with a $18.00 price target.
See the top stocks recommended by analysts >>
Marinus (MRNS)
In a report released yesterday, Andrew Tsai from Jefferies maintained a Buy rating on Marinus, with a price target of $22.00. The company’s shares closed last Tuesday at $9.44.
According to TipRanks.com, Tsai is a 3-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Marinus with a $19.11 average price target, implying an 112.6% upside from current levels. In a report issued on December 5, H.C. Wainwright also reiterated a Buy rating on the stock with a $27.00 price target.
Vertex Pharmaceuticals (VRTX)
In a report released yesterday, Michael Yee from Jefferies maintained a Hold rating on Vertex Pharmaceuticals, with a price target of $385.00. The company’s shares closed last Tuesday at $403.14, close to its 52-week high of $413.00.
According to TipRanks.com, Yee is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Vertex Pharmaceuticals with a $404.95 average price target, which is a 1.3% upside from current levels. In a report issued on December 4, Needham also maintained a Hold rating on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CVAC:
